Longshenrongfa Pharmaceutical Industry released its performance for the first three quarters, with a net profit attributable to the parent company of 27.0294 million yuan, an increase of 8.11%Zhitong·Oct 24, 2025 at 04:34 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: Net profit loss of 926,700 yuan in the third quarterZhitong·Oct 24, 2025 at 03:28 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: Zhao Zhengcai resigns as Chief Financial Officer, Xiao Rong takes overZhitong·Sep 26, 2025 at 03:45 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Manufacturing License"Zhitong·Sep 25, 2025 at 03:36 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: Tongmai Oral Liquid Approved for Market SaleZhitong·Sep 19, 2025 at 03:26 AM300534+2.69%
Gansu Longshenrongfa Pharmaceutical Industry announced the implementation of the 2025 semi-annual dividend distributionZhitong·Sep 15, 2025 at 03:21 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: In the first half of the year, the net profit attributable to the parent company was 27.9561 million yuan, a year-on-year increase of 27.48%Zhitong·Aug 22, 2025 at 03:55 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: Currently no relevant business and expansion plans in the brain-computer interface fieldZhitong·Aug 17, 2025 at 08:13 PM300534+2.69%
Longshenrongfa Pharmaceutical Industry: Obtained the drug production license after renewalZhitong·Aug 12, 2025 at 03:59 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Production License" and passed the drug GMP compliance inspectionZhitong·Aug 7, 2025 at 05:00 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: Received the approval notice for the supplementary application of the clinical trial of Buprenorphine oral dissolving filmZhitong·Jul 30, 2025 at 03:47 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: The holding subsidiary Guofang Testing has obtained the CNAS laboratory accreditation certificateZhitong·Jun 8, 2025 at 03:23 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry: A cash dividend of 0.2 yuan will be distributed for every 10 sharesZhitong·May 20, 2025 at 06:20 AM300534+2.69%
Longshenrongfa Pharmaceutical Industry released its first-quarter performance, with a net profit attributable to the parent company of 24.21 million yuan, an increase of 9.18%Zhitong·Apr 24, 2025 at 05:13 AM300534+2.69%
Midday Break | The three major indices of A-shares all rose36Kr·Mar 31, 2025 at 10:32 PM688390+1.17%3007630.00%
